FindTrial
Sign In

A clinical trial to study the effect of two formulations Haritkyadi Paryoga and Kampilak Tail Nasya in management of Nasagata Raktapitta w.s.r to Recurrent Epistaxis

A clinical study to evaluate the effect of Haritkyadi Paryoga and Kampilak Tail Nasya in the management of Nasagata Raktapitta w.s.r to Recurrent Epistaxis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048174
Enrollment
30
Registered
2022-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J989- Respiratory disorder, unspecified

Interventions

None listed

Sponsors

Principal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with active epistaxis and/or with history of epistaxis. Patients having any systemic disease i.e. hypertension, liver disease, kidney disease etc. Patients who consented to participate.

Exclusion criteria

Exclusion criteria: Congenital deformity. Pregnant patients. Patients not willing to be registered for the trial.

Design outcomes

Primary

MeasureTime frame
Relief in symptoms in patients of epistaxis.Timepoint: Relief in symptoms in patients of epistaxis.—

Secondary

MeasureTime frame
To study efficacy of Haritkyadi Prayoga and Kampilak Tail Nasya in improvements in nose bleeding of patients.Timepoint: 2 weeks—

Countries

India

Contacts

Public ContactDr Shilpa Thakur

Rajiv Gandhi Government Post Graduate Ayurvedic College And Hospital Paprola

bhardwajvijayant@gmail.com9418017568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026